-
Categories
-
Pharmaceutical Intermediates
-
Active Pharmaceutical Ingredients
-
Food Additives
- Industrial Coatings
- Agrochemicals
- Dyes and Pigments
- Surfactant
- Flavors and Fragrances
- Chemical Reagents
- Catalyst and Auxiliary
- Natural Products
- Inorganic Chemistry
-
Organic Chemistry
-
Biochemical Engineering
- Analytical Chemistry
-
Cosmetic Ingredient
- Water Treatment Chemical
-
Pharmaceutical Intermediates
Promotion
ECHEMI Mall
Wholesale
Weekly Price
Exhibition
News
-
Trade Service
On July 29, Hongbaoli recently released the 2020 semi-annual report.
In the first half of 2020, the company achieved operating income of 969,365,653.
08 yuan, a year-on-year decrease of 20.
88%; the net profit attributable to shareholders of the listed company was 51,824,147.
32 yuan, a year-on-year increase of 32.
86%
.
At the end of the reporting period, the company's total assets were 3,886,248,123.
45 yuan, an increase of 1.
78% over the end of the previous year; the net assets attributable to shareholders of the listed company were 1,593,710,905.
67 yuan, an increase of 1.
78% over the end of the previous year
.
It is understood that during the reporting period, operating income fell by 20.
88% year-on-year, mainly due to the impact of the epidemic, the decline in total product sales, and the decline in the average sales price
.
Operating costs fell by 24.
63% year-on-year, mainly due to the decline in the prices of raw and auxiliary materials such as propylene oxide and the decrease in sales volume
.
According to the data, Hongbaoli is mainly engaged in the research and development, production and sales of propylene oxide derivatives, including polyurethane rigid foam combination polyether, special polyether, isopropanolamine series products, and emerging materials polyurethane insulation board
.
